Evommune, Inc. (EVMN)
NYSE · Healthcare
Evommune, Inc. EBITDA 2024–2025
Evommune, Inc. annual/quarterly ebitda history and growth rate from 2024 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Evommune, Inc. ebitda for the quarter ending March 31, 2026 was -23.9 M, a 60.83% increase year-over-year.
- Evommune, Inc. annual ebitda for 2025 was -80.5 M, a 15.76% increase from 2024.
- Evommune, Inc. annual ebitda for 2024 was -69.5 M.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Evommune, Inc. EBITDA — FAQ
Evommune, Inc. (EVMN) ebitda over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see EVMN's ebitda history?
The chart and table above show Evommune, Inc.'s ebitda by year and by quarter, including the growth rate.